Characteristics of Florida and Texas Medicaid Children and Adolescents Prescribed an Antipsychotic with Metabolic Monitoring Classification Calendar Year 2017
| Characteristic . | Florida (N = 13 078) . | Texas (N = 28 000) . | Florida and Texas (N = 41 078) . |
|---|---|---|---|
| Behavioral health condition (groups not mutually exclusive), n (%) | |||
| Schizophrenia | 913 (7.0) | 1993 (7.1) | 2906 (7.1) |
| Autism without irritability | 2712 (20.7) | 4088 (14.6) | 6800 (16.6) |
| Autism with irritability | 443 (3.4) | 679 (2.4) | 1122 (2.7) |
| Bipolar | 2395 (18.3) | 6973 (24.9) | 9368 (22.8) |
| ADHD without conduct disorder | 7183 (54.9) | 16 854 (60.2) | 24 037 (58.5) |
| ADHD with conduct or disruptive behavioral disorder | 1051 (8.0) | 2970 (10.6) | 4021 (9.8) |
| Conduct or disruptive behavioral disorder, no ADHD | 407 (3.1) | 816 (2.9) | 1223 (3.0) |
| Anxiety or depression | 4359 (33.3) | 13 395 (47.8) | 17 754 (43.2) |
| Trauma and stressor and/or adjustment related disorder | 2692 (20.6) | 6396 (22.8) | 9088 (22.1) |
| Other mental health disorder | 5204 (39.8) | 13 974 (49.9) | 19 178 (46.7) |
| None of the above diagnoses | 784 (6.0) | 1559 (5.6) | 2343 (5.7) |
| Behavioral health diagnosis is accepted condition for use of antipsychotics, n (%) | 5961 (45.6) | 12 991 (46.4) | 18 952 (46.1) |
| Any cardiometabolic diagnosis,a n (%) | 2175 (16.6) | 5611 (20.0) | 7786 (19.0) |
| Enrolled in foster care, n (%) | 2021 (15.5) | 3811 (13.6) | 5832 (14.2) |
| During the year, ≥1 visit, n (%) | |||
| PCP | 4006 (30.6) | 8890 (31.8) | 12 896 (31.4) |
| MHP | 1564 (12.0) | 1765 (6.3) | 3329 (8.1) |
| PCP and MHP | 7508 (57.4) | 17 345 (62.0) | 24 853 (60.5) |
| Majority prescribing provider, n (%) | |||
| PCPb | 3986 (30.5) | 9366 (33.5) | 13 352 (32.5) |
| Pediatrician | 1052 (26.4) | 3135 (33.4) | 4187 (31.3) |
| Family medicine | 110 (2.8) | 878 (9.4) | 988 (7.4) |
| Internal medicine | 50 (1.3) | 122 (1.3) | 172 (1.3) |
| ARNP | 2179 (54.7) | 3822 (40.8) | 6001 (44.9) |
| PA | 563 (14.1) | 1381 (14.7) | 1944 (14.6) |
| MHP | 7801 (59.7) | 16 708 (59.7) | 24 509 (59.7) |
| Other | 1291 (9.9) | 1926 (6.9) | 3217 (7.8) |
| Age, mean (SD; range) | 12.6 (3.2; 3–17) | 12.0 (3.4; 3–17) | 12.2 (3.3; 3–17) |
| Female sex, n (%) | 4613 (35.2) | 9752 (34.8) | 14 365 (35.0) |
| Race and/or ethnicity, n (%) | |||
| Black (Non-Hispanic) | 1727 (13.2) | 4224 (15.1) | 5951 (14.5) |
| Hispanic | 1677 (12.8) | 11 080 (39.6) | 12 757 (31.1) |
| Other | 521 (4.0) | 120 (0.4) | 641 (1.6) |
| Unknown | 5008 (38.3) | 6575 (23.5) | 11 583 (28.2) |
| White (Non-Hispanic) | 4145 (31.7) | 6001 (21.4) | 10 146 (24.7) |
| RUCC, n (%) | |||
| Rural (4–9) | 484 (3.7) | 3430 (12.3) | 3914 (9.5) |
| Small or medium metropolitan (2–3) | 4893 (37.4) | 8559 (30.6) | 13 452 (32.8) |
| Urban (1) | 7701 (58.9) | 16 011 (57.2) | 23 712 (57.8) |
| SVI, n (%) | |||
| Fourth quartile (Most vulnerable) | 2796 (21.4) | 7599 (27.1) | 10 395 (25.3) |
| Third quartile | 3076 (23.4) | 7206 (25.7) | 10 282 (25.0) |
| Second quartile | 3666 (28.0) | 6605 (23.6) | 10 271 (25.0) |
| First quartile (least vulnerable) | 3540 (27.1) | 6590 (23.5) | 10 130 (24.7) |
| Characteristic . | Florida (N = 13 078) . | Texas (N = 28 000) . | Florida and Texas (N = 41 078) . |
|---|---|---|---|
| Behavioral health condition (groups not mutually exclusive), n (%) | |||
| Schizophrenia | 913 (7.0) | 1993 (7.1) | 2906 (7.1) |
| Autism without irritability | 2712 (20.7) | 4088 (14.6) | 6800 (16.6) |
| Autism with irritability | 443 (3.4) | 679 (2.4) | 1122 (2.7) |
| Bipolar | 2395 (18.3) | 6973 (24.9) | 9368 (22.8) |
| ADHD without conduct disorder | 7183 (54.9) | 16 854 (60.2) | 24 037 (58.5) |
| ADHD with conduct or disruptive behavioral disorder | 1051 (8.0) | 2970 (10.6) | 4021 (9.8) |
| Conduct or disruptive behavioral disorder, no ADHD | 407 (3.1) | 816 (2.9) | 1223 (3.0) |
| Anxiety or depression | 4359 (33.3) | 13 395 (47.8) | 17 754 (43.2) |
| Trauma and stressor and/or adjustment related disorder | 2692 (20.6) | 6396 (22.8) | 9088 (22.1) |
| Other mental health disorder | 5204 (39.8) | 13 974 (49.9) | 19 178 (46.7) |
| None of the above diagnoses | 784 (6.0) | 1559 (5.6) | 2343 (5.7) |
| Behavioral health diagnosis is accepted condition for use of antipsychotics, n (%) | 5961 (45.6) | 12 991 (46.4) | 18 952 (46.1) |
| Any cardiometabolic diagnosis,a n (%) | 2175 (16.6) | 5611 (20.0) | 7786 (19.0) |
| Enrolled in foster care, n (%) | 2021 (15.5) | 3811 (13.6) | 5832 (14.2) |
| During the year, ≥1 visit, n (%) | |||
| PCP | 4006 (30.6) | 8890 (31.8) | 12 896 (31.4) |
| MHP | 1564 (12.0) | 1765 (6.3) | 3329 (8.1) |
| PCP and MHP | 7508 (57.4) | 17 345 (62.0) | 24 853 (60.5) |
| Majority prescribing provider, n (%) | |||
| PCPb | 3986 (30.5) | 9366 (33.5) | 13 352 (32.5) |
| Pediatrician | 1052 (26.4) | 3135 (33.4) | 4187 (31.3) |
| Family medicine | 110 (2.8) | 878 (9.4) | 988 (7.4) |
| Internal medicine | 50 (1.3) | 122 (1.3) | 172 (1.3) |
| ARNP | 2179 (54.7) | 3822 (40.8) | 6001 (44.9) |
| PA | 563 (14.1) | 1381 (14.7) | 1944 (14.6) |
| MHP | 7801 (59.7) | 16 708 (59.7) | 24 509 (59.7) |
| Other | 1291 (9.9) | 1926 (6.9) | 3217 (7.8) |
| Age, mean (SD; range) | 12.6 (3.2; 3–17) | 12.0 (3.4; 3–17) | 12.2 (3.3; 3–17) |
| Female sex, n (%) | 4613 (35.2) | 9752 (34.8) | 14 365 (35.0) |
| Race and/or ethnicity, n (%) | |||
| Black (Non-Hispanic) | 1727 (13.2) | 4224 (15.1) | 5951 (14.5) |
| Hispanic | 1677 (12.8) | 11 080 (39.6) | 12 757 (31.1) |
| Other | 521 (4.0) | 120 (0.4) | 641 (1.6) |
| Unknown | 5008 (38.3) | 6575 (23.5) | 11 583 (28.2) |
| White (Non-Hispanic) | 4145 (31.7) | 6001 (21.4) | 10 146 (24.7) |
| RUCC, n (%) | |||
| Rural (4–9) | 484 (3.7) | 3430 (12.3) | 3914 (9.5) |
| Small or medium metropolitan (2–3) | 4893 (37.4) | 8559 (30.6) | 13 452 (32.8) |
| Urban (1) | 7701 (58.9) | 16 011 (57.2) | 23 712 (57.8) |
| SVI, n (%) | |||
| Fourth quartile (Most vulnerable) | 2796 (21.4) | 7599 (27.1) | 10 395 (25.3) |
| Third quartile | 3076 (23.4) | 7206 (25.7) | 10 282 (25.0) |
| Second quartile | 3666 (28.0) | 6605 (23.6) | 10 271 (25.0) |
| First quartile (least vulnerable) | 3540 (27.1) | 6590 (23.5) | 10 130 (24.7) |
ADHD, attention-deficit/hyperactivity disorder; ARNP, advanced registered nurse practitioner; PA, physician’s assistant.
≥1 of the following diagnoses: obesity, morbid obesity, overweight, abnormal weight gain, metabolic syndrome, hypertension, elevated blood pressure without hypertension, hyperlipidemia, acquired acanthosis nigricans, hyperinsulinism, impaired fasting glucose, hypercholesteremia, impaired glucose tolerance, hypertriglyceridemia, mixed hyperlipidemia, type 2 diabetes, and nonalcoholic fatty liver disease.
PCP subspecialty percentages are among those whose majority prescribing provider is a PCP.